Testing effectiveness (Phase 2)Active Not RecruitingNCT04775550What this trial is testingDARA RVD For High Risk SMMWho this might be right forHigh-risk Smoldering Multiple MyelomaMultiple Myeloma Omar Nadeem, MD 61
Testing effectiveness (Phase 2)Ended earlyNCT00240162What this trial is testingPTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Washington University School of Medicine 21
Large-scale testing (Phase 3)UnknownNCT00002989What this trial is testingCombination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more European Organisation for Research and Treatment of Cancer - EORTC 207
Testing effectiveness (Phase 2)Study completedNCT02034110What this trial is testingEfficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersWho this might be right forCancer Novartis Pharmaceuticals 206
Testing effectiveness (Phase 2)UnknownNCT00311337What this trial is testingVELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)Who this might be right forMultiple Myeloma University of Wuerzburg 61
Testing effectiveness (Phase 2)Study completedNCT02416206What this trial is testingHigh Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple MyelomaWho this might be right forMultiple Myeloma Northside Hospital, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT00258206What this trial is testingRituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Large-scale testing (Phase 3)Study completedNCT00551928What this trial is testingLenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma PatientsWho this might be right forMultiple MyelomaNewly Diagnosed Patients Fondazione EMN Italy Onlus 402
Not applicableStudy completedNCT05150353What this trial is testingDetection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP)Who this might be right forAmyloidSystemic Amyloidosis GCS Ramsay Santé pour l'Enseignement et la Recherche 128
Testing effectiveness (Phase 2)Study completedNCT00833560What this trial is testingBortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose ChemotherapyWho this might be right forMultiple Myeloma Janssen-Cilag G.m.b.H 401
Testing effectiveness (Phase 2)Study completedNCT00006219What this trial is testingChemoprevention Therapy in Treating Patients at High Risk of Developing Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT03651128What this trial is testingEfficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma Celgene 386
Testing effectiveness (Phase 2)Study completedNCT00781170What this trial is testingDose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple MyelomaWho this might be right forMultiple MyelomaStem Cell Transplantation Universitätsklinikum Hamburg-Eppendorf 20
Testing effectiveness (Phase 2)WithdrawnNCT02114502What this trial is testingCarfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in MyelomaWho this might be right forMyeloma M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT04813653What this trial is testingCyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma CellsWho this might be right forMultiple Myeloma in RelapseMultiple Myeloma, Refractory Tel-Aviv Sourasky Medical Center 3
Testing effectiveness (Phase 2)WithdrawnNCT00004039What this trial is testingCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Looking for participantsNCT04558931What this trial is testingClinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple MyelomaWho this might be right forMultiple Myeloma Karolinska Institutet 62
Large-scale testing (Phase 3)UnknownNCT02270307What this trial is testingMSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) ProphylaxisWho this might be right forLeukemiaMultiple Myeloma National Research Center for Hematology, Russia 40
Large-scale testing (Phase 3)Study completedNCT02252172What this trial is testingStudy Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 737
Testing effectiveness (Phase 2)Ended earlyNCT02906332What this trial is testingPembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Hackensack Meridian Health 12